Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China

Key facts

Sponsor

Beijing Tiantan Hospital

Principal Investigator

Wang Shuo, MD

Beijing Tiantan Hospital

Intervention

Multi-disciplinary assessment(other)

Enrollment

2000 enrolled

Eligibility

1-80 years · All sexes

Timeline

2011 – 2033

Study locations (1)

• Capital medical university affiliated Beijing Tiantan hospital, Beijing, Beijing Municipality, China

Collaborators

Beijing Neurosurgical Institute · Peking University International Hospital · West China Hospital · First Affiliated Hospital of Harbin Medical University · Sichuan Provincial People's Hospital · The First Hospital of Jilin University · Shanxi Provincial People's Hospital · The Second Hospital of Shandong University · The First Affiliated Hospital of Zhengzhou University · First Affiliated Hospital of Xinjiang Medical University · The General Hospital of Central Theater Command · The Affiliated Hospital Of Guizhou Medical University · First Affiliated Hospital of Guangxi Medical University · Tianjin Medical University Second Hospital · The First Affiliated Hospital of Shanxi Medical University · Shengjing Hospital · Second Affiliated Hospital of Guangzhou Medical University · Hainan People's Hospital · The Second Affiliated Hospital of Kunming Medical University · The Affiliated Hospital of Qingdao University · Second Xiangya Hospital of Central South University · Second Affiliated Hospital of Soochow University · General Hospital of Ningxia Medical University · Lanzhou University Second Hospital · The First Affiliated Hospital of Anhui Medical University · First Affiliated Hospital of Zhejiang University · Qilu Hospital of Shandong University · Jining Medical University · First Affiliated Hospital of Chongqing Medical University · First Affiliated Hospital of Fujian Medical University · Shandong Provincial Hospital · The Affiliated Hospital of Xuzhou Medical University · Henan Provincial People's Hospital · Binzhou Medical University · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Brain arteriovenous malformation

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07519876
  Pulmonary Embolism and Right-to-Left Shunts
  Tufts Medical Center
• RECRUITINGPHASE2, PHASE3NCT06264531
  Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations
  Fondation Ophtalmologique Adolphe de Rothschild
• RECRUITINGNCT07118631
  Clinical Study on Emergency Treatment of Cerebral Arteriovenous Malformation Bleeding
  Beijing Tiantan Hospital
• RECRUITINGPHASE2NCT06913725
  An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations
  Xuanwu Hospital, Beijing
• RECRUITINGNANCT07314047
  The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation
  MicroPort NeuroTech Co., Ltd.
• RECRUITINGNCT06259292
  Comprehensive HHT Outcomes Registry of the United States (CHORUS)
  Cure HHT
• RECRUITINGNCT05449106
  Evaluation of Clinical Outcomes of Unruptured bAVMs Treated With Medical Management Alone Based on Multimodal CT
  Beijing Tiantan Hospital
• RECRUITINGNCT04927156
  Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
  Balt Extrusion

See all trials for Brain arteriovenous malformation →